Cardinal Health Expands At‑Home Care Footprint with $360 Million Acquisitions
Wed, September 09, 2026Cardinal Health (NYSE: CAH) has taken definitive steps to strengthen its at‑home care offerings. On July 20, 2026, the company announced acquisitions of AdaptHealth’s diabetes health business and urology-focused Strive Medical for a combined $360 million in cash, marking a significant expansion of its at‑Home Solutions segment.
Acquisitions to Deepen Home-Based Services
The deals are part of Cardinal Health’s broader strategy to build a vertically integrated platform that delivers patient‑centric care beyond traditional hospital settings. The diabetes unit acquisition enhances the company’s chronic disease management capabilities, while the Strive Medical acquisition adds depth in urology supplies.
These transactions align with Cardinal Health’s ongoing emphasis on growing its at‑home care capabilities through both organic investment and targeted acquisitions. The company stated these businesses will integrate into its existing infrastructure to bolster service delivery to patients in home environments.
Context and Strategic Significance
This follows Cardinal Health’s earlier pivot toward specialty and home-based healthcare, including prior acquisitions in multi‑specialty physician services. The new expansions underscore continued investment in high‑margin, patient‑oriented services within its integrated healthcare model.
Stock Performance Note
As of September 8, 2026, Cardinal Health shares were priced at $240.49, down 1.4% on the day. While the recent acquisition announcements preceded this date, there is no verified attribution of stock movement to these deals.
Why It Matters
By integrating chronic care and specialty device capabilities into its at‑home platform, Cardinal Health enhances its ability to meet growing demand for convenient, value‑driven healthcare delivery. Investors and industry watchers will likely view these moves as reinforcing the firm’s shift toward higher-growth, specialist segments within the broader healthcare services landscape.
Looking ahead, the successful integration and performance of these units will be key metrics to monitor. The company’s upcoming investor events or financial disclosures may shed light on how these acquisitions impact segment performance and overall strategy execution.